Back to Search
Start Over
IDEAYA Biosciences Announces Proffered Paper Oral Presentation at ESMO 2023 for Phase 2 Clinical Data Update for Darovasertib and Crizotinib Combination in Metastatic Uveal Melanoma
- Source :
- Plus Company Updates. October 19, 2023
- Publication Year :
- 2023
-
Abstract
- SOUTH SAN FRANCISCO, Calif: IDEAYA Biosciences, Inc. has issued the following news release: IDEAYA Biosciences, Inc. (Nasdaq:IDYA), a precision medicine oncology company committed to the discovery and development of targeted [...]
Details
- Language :
- English
- Database :
- Gale General OneFile
- Journal :
- Plus Company Updates
- Publication Type :
- News
- Accession number :
- edsgcl.769999780